{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:44:10Z","timestamp":1792003450664,"version":"4.4.0"},"reference-count":21,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2013]]},"DOI":"10.7883\/yoken.66.222","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T23:34:36Z","timestamp":1369265676000},"page":"222-225","source":"Crossref","is-referenced-by-count":13,"title":["Screening for Group B Streptococci with Reduced Penicillin Susceptibility in Clinical Isolates Obtained between 1977 and 2005"],"prefix":"10.7883","volume":"66","author":[{"given":"Kouji","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Wachino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satowa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunikazu","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshichika","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. Baker, C.J. (2000): Group B streptococcal infections. p. 222–237. In<\/i> D.L. Stevens and E.L. Kaplan (ed.), Streptococcal Infections. Clinical Aspects, Microbiology, and Molecular Pathogenesis. Oxford University Press, Oxford."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306243282503"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Jackson, L.A., Hilsdon, R., Farley, M.M., et al. (1995): Risk factors for group B streptococcal disease in adults. Ann. Intern. Med., 123, 415–420.","DOI":"10.7326\/0003-4819-123-6-199509150-00003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schuchat, A. (1999): Group B streptococcus. Lancet, 353, 51–56.","DOI":"10.1016\/S0140-6736(98)07128-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Heath, P.T., Balfour, G., Weisner, A.M., et al. (2004): Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet, 363, 292–294.","DOI":"10.1016\/S0140-6736(03)15389-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schuchat, A. (1998): Epidemiology of Group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev., 11, 497–513.","DOI":"10.1128\/CMR.11.3.497"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stoll, B.J., Hansen, N., Fanaroff, A.A., et al. (2002): Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med., 347, 240–247.","DOI":"10.1056\/NEJMoa012657"},{"key":"8","unstructured":"8. Schrag, S., Gorwitz, R., Fulz-Butts, K., et al. (2002): Prevention of perinatal group B streptococcal disease. Morbid. Mortal. Wkly. Rep., 51(RR-11), 1–22."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1552"},{"key":"10","unstructured":"10. Edwards, M.S. (2008): Group B streptococcal conjugate vaccine. A timely concept for which the time has come. Hum. Vaccin., 4, 444–448."},{"key":"11","unstructured":"11. Clinical and Laboratory Standards Institute (2006): Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth informational supplement, M100-S16. CLSI, Wayne, PA."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kimura, K., Suzuki, S., Wachino, J., et al. (2008): First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother., 52, 2890–2897.","DOI":"10.1128\/AAC.00185-08"},{"key":"13","unstructured":"13. Dahesh, S., Hensler, M.E., Van Sorge, N.M., et al. (2008): Point mutation in the group B streptococcal pbp2x<\/i> gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob. Agents Chemother., 52, 2915–2918."},{"key":"14","unstructured":"14. Gaudreau, C., Lecours, R., Ismail, J., et al. (2009): Prosthetic hip joint infection with a Streptococcus agalactiae<\/i> isolate not susceptible to penicillin G and ceftriaxone. J. Antimicrob. Chemother., 65, 594–595."},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Nagano, N., Nagano, Y., Kimura, K., et al. (2008): Genetic heterogeneity in pbp<\/i> genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother., 52, 4258–4267.","DOI":"10.1128\/AAC.00596-08"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Kimura, K., Nagano, N., Nagano, Y., et al. (2011): Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in Japan. J. Antimicrob. Chemother., 66, 2460–2464.","DOI":"10.1093\/jac\/dkr352"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Nagano, N., Kimura, K., Nagano, Y., et al. (2009): Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from sacral decubitus ulcer. J. Antimicrob. Chemother., 64, 1326–1328.","DOI":"10.1093\/jac\/dkp374"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Nagano, N., Nagano, Y., Toyama, M., et al. (2012): Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J. Antimicrob. Chemother., 67, 849–856.","DOI":"10.1093\/jac\/dkr546"},{"key":"19","unstructured":"20. Kimura, K., Nagano, N., Nagano, Y., et al. (2012): High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. J. Antimicrob. Chemother. doi: 10.1093\/jac\/dsk423."},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Murayama, S.Y., Seki, C., Sakata, H., et al. (2009): Capsular type and antibiotic resistance in Streptococcus agalactiae<\/i> isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother., 53, 2650–2653.","DOI":"10.1128\/AAC.01716-08"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Kimura, K., Wachino, J., Kurokawa, H., et al. (2009): Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility. J. Clin. Microbiol., 47, 4154–4157.","DOI":"10.1128\/JCM.02063-08"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T21:58:33Z","timestamp":1621547913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/66\/3\/66_222\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.66.222","relation":{},"ISSN":["1344-6304"],"issn-type":[{"value":"1344-6304","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}